CJC-1295 / Ipa 2X Blend (10mg / 10mg)
Also known as · CJC-1295 No-DAC + Ipamorelin 10/10
Overview
A 1:1 (10 mg / 10 mg) higher-content version of the CJC-1295 No-DAC + Ipamorelin blend, allowing extended multi-week studies from a single vial.
Research profile · for clinicians
Based on research: same GHRH + GHRP synergy as the 5/5 preparation at higher content per vial, supporting extended multi-week study protocols from a single reconstitution.
Mechanism of action
Mechanism identical to the 5/5 ratio — combined GHRH-R + GHSR-1a activation amplifies endogenous pulsatile GH release.
Research record
- [01]Mechanistic basis is the same body of GHRH + GHRP synergy literature.
Selected references
Synergism of GHRH and GHRPs
J. Clin. Endocrinol. Metab., 1994